Gilead Sciences Inc (GILD)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 19,330,000 | 22,833,000 | 21,209,000 | 21,064,000 | 18,221,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $19,330,000K
= 0.00
The debt-to-equity ratio for Gilead Sciences Inc has consistently been 0.00 through the years 2020 to 2024. This indicates that the company's total debt is minimal or non-existent compared to its shareholders' equity. A low or zero debt-to-equity ratio suggests that Gilead Sciences has been financing its operations primarily through equity rather than debt, which may signify a strong financial position and lower financial risk. It also implies that the company may have a conservative approach to leverage, potentially reducing interest expenses and increasing investor confidence. However, it's important to note that while a low debt-to-equity ratio can be seen as positive, it may also indicate missed opportunities for leveraging debt for potential growth or capitalizing on financial leverage for higher returns.
Peer comparison
Dec 31, 2024